APA

Malaviya R., Chen C. L., Navara C., Malaviya R., Liu X. P., Keenan M., Waurzyniak B. & Uckun F. M. (20001220). Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3', 5'-dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97). : The Journal of pharmacology and experimental therapeutics.

Chicago

Malaviya R, Chen C L, Navara C, Malaviya R, Liu X P, Keenan M, Waurzyniak B and Uckun F M. 20001220. Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3', 5'-dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97). : The Journal of pharmacology and experimental therapeutics.

Harvard

Malaviya R., Chen C. L., Navara C., Malaviya R., Liu X. P., Keenan M., Waurzyniak B. and Uckun F. M. (20001220). Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3', 5'-dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97). : The Journal of pharmacology and experimental therapeutics.

MLA

Malaviya R, Chen C L, Navara C, Malaviya R, Liu X P, Keenan M, Waurzyniak B and Uckun F M. Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3', 5'-dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97). : The Journal of pharmacology and experimental therapeutics. 20001220.